Abstract
Carefully monitored levothyroxine suppressive therapy is not associated with bone loss in premenopausal women
Full Text
Sign-in/Register to access full text options
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: The Journal of Clinical Endocrinology & Metabolism
Paper Title
Journal
Date